Sun Pharmaceutical Industries Limited (BOM:524715)
India · Delayed Price · Currency is INR 1,634.40
+21.85 (1.35%)
At close: Jan 22, 2026
BOM:524715 Market Cap
BOM:524715 has a market cap or net worth of 3.92 trillion as of January 23, 2026. Its market cap has decreased by -11.54% in one year.
Market Cap
3.92T
Enterprise Value
3.70T
Revenue
549.64B
Ranking
n/a
PE Ratio
37.52
Stock Price
1,634.40
Market Cap Chart
Since February 15, 2001, BOM:524715's market cap has increased from 27.61B to 3.92T, an increase of 14,101.00%. That is a compound annual growth rate of 21.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 3.92T | -5.11% |
| Dec 31, 2025 | 4.13T | -8.83% |
| Dec 31, 2024 | 4.53T | 49.78% |
| Dec 29, 2023 | 3.02T | 25.77% |
| Dec 30, 2022 | 2.40T | 18.41% |
| Dec 31, 2021 | 2.03T | 42.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Torrent Pharmaceuticals | 1.36T |
| Dr. Reddy's Laboratories | 1.01T |
| Lupin | 988.99B |
| Abbott India | 588.57B |
| GlaxoSmithKline Pharmaceuticals | 403.16B |
| J. B. Chemicals & Pharmaceuticals | 297.75B |
| AstraZeneca Pharma India | 208.68B |
| Jubilant Pharmova | 153.37B |